Thoughts on the 2019 American Academy of Sleep Medicine position statement on chronic opioid therapy and sleep

Gilles J Lavigne; Alberto Herrero Babiloni; Pierre Mayer; Raoul Daoust; Marc O Martel

doi:10.5664/jcsm.8368

Thoughts on the 2019 American Academy of Sleep Medicine position statement on chronic opioid therapy and sleep

J Clin Sleep Med. 2020 May 15;16(5):831-833. doi: 10.5664/jcsm.8368. Epub 2020 Feb 13.

Authors

Gilles J Lavigne^{1

2}, Alberto Herrero Babiloni^{1

2

3}, Pierre Mayer⁴, Raoul Daoust^{5

6}, Marc O Martel⁷

Affiliations

¹ Center for Advanced Research in Sleep Medicine, Research Centre, Hôpital du Sacré-Coeur de Montréal, Montréal, Québec, Canada.
² Faculty of Dental Medicine, Université de Montréal, Montréal, Québec, Canada.
³ Division of Experimental Medicine, McGill University, Montréal, Québec, Canada.
⁴ Respiratory Medicine and Sleep, Centre Hospitalier de l'Universite de Montreal, Montréal, Québec, Canada.
⁵ Faculty of Medicine, University of Montreal, Montreal, Québec, Canada.
⁶ Department of Emergency Medicine, Research Centre, Hôpital du Sacré-Coeur de Montréal, Montréal, Québec, Canada.
⁷ Faculty of Dentistry and Department of Anesthesia, McGill University, Montréal, Québec, Canada.

Abstract

Lavigne GJ, Herrero Babiloni A, Mayer P, Daoust R, Martel MO. Thoughts on the 2019 American Academy of Sleep Medicine position statement on chronic opioid therapy and sleep. J Clin Sleep Med. 2020;16(5):831–833.

Publication types

Letter
Comment

MeSH terms

Academies and Institutes
Analgesics, Opioid*
Humans
Sleep
Sleep Medicine Specialty*
United States

Substances

Analgesics, Opioid